Here, our aim was to test customized fluorometric methods for assaying five lysosomal enzymes in screens for MPS I, MPS VI, Fabry, Gaucher, and Pompe diseases, plus assays of biomarkers, such as blood chitotriosidase and urinary glycosaminoglycans. This evidence concerns the gene CHIT1 and Scheie syndrome.